US Obesity Rates Hit Record High Amid New Drug Hope
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Exclusive analysis reveals how Britain's growing obesity epidemic is pushing the NHS toward an impossible choice between routine care and weight-related treatments as waiting lists hit record highs.
Groundbreaking research from Lund University shows obesity significantly increases risk for numerous cancers including leukaemia, thyroid and breast cancer, with UK health experts calling for urgent action.
Groundbreaking research exposes how obesity has become the primary driver behind rising cancer rates in older adults, with stark warnings for UK healthcare systems.
Groundbreaking research exposes Australia's alarming obesity divide, with detailed analysis revealing which suburbs are winning and losing the battle of the bulge.
New data reveals America's obesity epidemic has worsened dramatically, with 22 states reaching unprecedented levels. Health experts warn of severe consequences for healthcare systems and national wellbeing.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
A landmark UNICEF report reveals a historic shift: ultra-processed foods have led to more children globally being obese than underweight for the first time, signalling a urgent public health crisis.
Exclusive investigation reveals the UK towns drowning in fast food, with Jaywick, Essex, crowned the nation's takeaway capital. Health experts sound the alarm on obesity crisis.
Exclusive investigation reveals a record number of young children, some just three years old, are being referred to specialist obesity services amid a growing national health emergency.
New research from the University of Glasgow颠覆ляет traditional thinking, showing that body fat percentage—not BMI—is the critical predictor of heart failure risk, with significant implications for public health strategies.
Breakthrough UK study reveals Retatrutide, the new triple-action 'Godzilla' weight loss injection, is dramatically more effective than its predecessors, helping patients lose up to 24% of their body weight in just 48 weeks.
Discover how Hims & Hers' new personalised weight loss programme, featuring GLP-1 medications and holistic support, is set to transform the approach to healthy living in the UK.
A mother's shocking journey from a dangerous 500-calorie diet to a life-saving NHS health transformation. Discover how she lost 5 stone and reclaimed her health.
Exclusive: A dramatic price war has broken out for 'game-changer' weight loss drugs Wegovy and Mounjaro in the UK, making them more accessible through private providers but raising concerns for the NHS.
A British mother who lost seven stone on diabetes drug Mounjaro issues urgent health warning after suffering severe side effects including vomiting brown liquid and excruciating stomach pain.
The NHS is spearheading a major crackdown on sugar and salt in baby food. Discover how new mandatory limits and a ban on sweeteners aim to reshape children's health and combat the UK's obesity crisis from weaning age.
A damning new report reveals UK supermarkets are making healthy food up to twice as expensive as unhealthy alternatives through aggressive promotions, disproportionately harming low-income families.
Tennis legend Serena Williams discusses her experience with GLP-1 weight loss medication in a powerful personal essay, challenging stigma and advocating for body autonomy.
Groundbreaking research suggests popular weight loss injections like Wegovy and Ozempic could significantly lower the risk of obesity-related cancers, offering a potential double benefit for millions.
Groundbreaking UK research reveals women who give birth before 37 weeks, especially those with diabetes or obesity, are significantly more likely to develop heart failure later in life. Experts call for targeted healthcare strategies.
Public staircases in South Korea now display labels showing calories burned, igniting a fierce debate over body image and potential harm to those with eating disorders.
The NHS launches its most significant diabetes care reform in a decade, offering Ozempic-style injections to thousands in a bid to tackle obesity-driven type 2 cases and potentially slash future complications.
A leading UK paediatrician issues a stark warning to parents about the potential health risks, including obesity and tooth decay, associated with popular children's gummy vitamin supplements.
Vets issue urgent alert after dogs ingest diabetes drug Ozempic, sparking fears over pet obesity and accidental poisoning.
Discover how to transition from Mounjaro to Wegovy safely and avoid weight regain, as explained by a leading GP. Plus, why the 'King Kong' jab could triple in price.
New research suggests that popular weight loss injections may lead to rebound weight gain, raising concerns among health professionals.
A groundbreaking programme in Las Vegas provides teachers with free lap-band surgery to combat obesity, sparking debate on workplace health incentives.
The soaring cost of Mounjaro, a promising weight loss drug, has sparked debate over affordability and access in UK pharmacies. Experts weigh in on the implications.
A woman's astonishing weight loss journey saw her drop a staggering 25 stone, reclaiming her health and happiness. Discover her inspiring story.